• Reference Citation Analysis
  • v
  • v
  • Find an Article
Download
Number Select Citation Analysis of Yun Dai's Published Articles
1 Wang W, Sun Y, Liu X, Kumar SK, Jin F, Dai Y. Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy. Front Oncol 2022;12:859455. [PMID: 35574302 DOI: 10.3389/fonc.2022.859455] [Cited by in Crossref: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
2 Yang H, Sun Y, Li Q, Jin F, Dai Y. Diverse Epigenetic Regulations of Macrophages in Atherosclerosis. Front Cardiovasc Med 2022;9:868788. [PMID: 35425818 DOI: 10.3389/fcvm.2022.868788] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
3 Zhang L, Tan W, Yang H, Zhang S, Dai Y. Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer. Front Oncol 2022;12:831949. [PMID: 35402283 DOI: 10.3389/fonc.2022.831949] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
4 Sun D, Zou Y, Song L, Han S, Yang H, Chu D, Dai Y, Ma J, O'Driscoll CM, Yu Z, Guo J. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B 2022;12:378-93. [PMID: 35127393 DOI: 10.1016/j.apsb.2021.06.005] [Cited by in Crossref: 4] [Cited by in RCA: 5] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
5 Ye L, Jin F, Kumar SK, Dai Y. The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets 2021;:1-22. [PMID: 34821176 DOI: 10.1080/14728222.2021.2011206] [Cited by in Crossref: 5] [Cited by in RCA: 3] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
6 Yang H, Song L, Sun B, Chu D, Yang L, Li M, Li H, Dai Y, Yu Z, Guo J. Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing. Mater Today Bio 2021;12:100139. [PMID: 34632363 DOI: 10.1016/j.mtbio.2021.100139] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
7 Zhou L, Zhang Y, Meads MB, Dai Y, Ning Y, Hu X, Li L, Sharma K, Nkwocha J, Parker R, Bui D, McCarter J, Kramer L, Purcell C, Sudalagunta PR, Canevarolo RR, Coelho Siqueira Silva MD, De Avila G, Alugubelli RR, Silva AS, Kmeiciak M, Ferreira-Gonzalez A, Shain KH, Grant S. IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms. Blood Adv 2021;5:3776-88. [PMID: 34464977 DOI: 10.1182/bloodadvances.2020003597] [Cited by in Crossref: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
8 Yang T, Liu X, Kumar SK, Jin F, Dai Y. Decoding DNA methylation in epigenetics of multiple myeloma. Blood Rev 2021;:100872. [PMID: 34384602 DOI: 10.1016/j.blre.2021.100872] [Cited by in Crossref: 3] [Cited by in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
9 Chen K, Yang Q, Zha J, Deng M, Zhou Y, Fu G, Bi S, Feng L, Xu-Monette ZY, Chen XL, Fu G, Dai Y, Young KH, Xu B. Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia. Cell Death Dis 2020;11:778. [PMID: 32948748 DOI: 10.1038/s41419-020-02972-2] [Cited by in Crossref: 11] [Cited by in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
10 Ding X, Huang W, Peng Y, Fan H, Zhu Y, Liu X, Yang Y, Guo Q, Qiu L, Dai Y, Zou D, Jin F. Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma. Ann Hematol 2020;99:1331-9. [PMID: 32382775 DOI: 10.1007/s00277-019-03800-0] [Cited by in Crossref: 3] [Cited by in RCA: 2] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
11 Yao G, Man YH, Li AR, Guo Y, Dai Y, Wang P, Zhou YF. NO up-regulates migraine-related CGRP via activation of an Akt/GSK-3β/NF-κB signaling cascade in trigeminal ganglion neurons. Aging (Albany NY) 2020;12:6370-84. [PMID: 32276265 DOI: 10.18632/aging.103031] [Cited by in Crossref: 11] [Cited by in RCA: 7] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
12 Jin F, Zheng X, Yang Y, Yao G, Ye L, Doeppner TR, Hermann DM, Wang H, Dai Y. Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFα and angiogenic VEGF. Aging (Albany NY) 2019;11:328-49. [PMID: 30659163 DOI: 10.18632/aging.101726] [Cited by in Crossref: 11] [Cited by in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
13 Ye J, Zha J, Shi Y, Li Y, Yuan D, Chen Q, Lin F, Fang Z, Yu Y, Dai Y, Xu B. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Clin Epigenetics 2019;11:137. [PMID: 31590682 DOI: 10.1186/s13148-019-0723-0] [Cited by in Crossref: 23] [Cited by in RCA: 21] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
14 Dai Y, Jin F, Wu W, Kumar SK. Cell cycle regulation and hematologic malignancies. Blood Science 2019;1:34-43. [PMID: 35402801 DOI: 10.1097/bs9.0000000000000009] [Cited by in Crossref: 7] [Cited by in RCA: 6] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
15 Zhou L, Zhang Y, Leng Y, Dai Y, Kmieciak M, Kramer L, Sharma K, Wang Y, Craun W, Grant S. The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo. J Hematol Oncol 2019;12:25. [PMID: 30845975 DOI: 10.1186/s13045-019-0713-x] [Cited by in Crossref: 14] [Cited by in RCA: 11] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
16 Shi C, Guan Y, Zeng L, Liu G, Zhu Y, Xu H, Lu Y, Liu J, Guo J, Feng X, Zhao X, Jiang W, Li G, Li G, Dai Y, Jin F, Li W, Zhou W. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma. Int J Oncol 2018;53:1138-48. [PMID: 29956730 DOI: 10.3892/ijo.2018.4462] [Cited by in Crossref: 4] [Cited by in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
17 Wu C, Yang T, Liu Y, Lu Y, Yang Y, Liu X, Liu X, Ye L, Sun Y, Wang X, Li Q, Yang P, Yu X, Gao S, Kumar S, Jin F, Dai Y, Li W. ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma. Cancer Med 2018;7:3899-911. [PMID: 29926531 DOI: 10.1002/cam4.1596] [Cited by in Crossref: 17] [Cited by in RCA: 16] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
18 Li Y, Ning Q, Shi J, Chen Y, Jiang M, Gao L, Huang W, Jing Y, Huang S, Liu A, Hu Z, Liu D, Wang L, Nervi C, Dai Y, Zhang MQ, Yu L. A novel epigenetic AML1-ETO/THAP10/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis. EMBO Mol Med 2017;9:933-49. [PMID: 28539478 DOI: 10.15252/emmm.201607180] [Cited by in Crossref: 16] [Cited by in RCA: 11] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
19 Jin F, Lin H, Gao S, Wang H, Yan H, Guo J, Hu Z, Jin C, Wang Y, Wang Z, Zhao Y, Liu Y, Zheng X, Tan Y, Li W, Dai Y, Yang Y. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation. Oncotarget 2017;8:51-63. [PMID: 27980216 DOI: 10.18632/oncotarget.13916] [Cited by in Crossref: 17] [Cited by in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
20 Turner JG, Kashyap T, Dawson JL, Gomez J, Bauer AA, Grant S, Dai Y, Shain KH, Meads M, Landesman Y, Sullivan DM. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma. Oncotarget 2016;7:78896-909. [PMID: 27806331 DOI: 10.18632/oncotarget.12969] [Cited by in Crossref: 60] [Cited by in RCA: 49] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
21 Jin F, Hagemann N, Sun L, Wu J, Doeppner TR, Dai Y, Hermann DM. High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation. Angiogenesis 2018;21:381-94. [PMID: 29450744 DOI: 10.1007/s10456-018-9603-z] [Cited by in Crossref: 25] [Cited by in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
22 Zhou L, Zhang Y, Sampath D, Leverson J, Dai Y, Kmieciak M, Nguyen M, Orlowski RZ, Grant S. Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivo. Br J Cancer 2018;118:388-97. [PMID: 29241222 DOI: 10.1038/bjc.2017.432] [Cited by in Crossref: 19] [Cited by in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
23 Zhang Y, Zhou L, Leng Y, Dai Y, Orlowski RZ, Grant S. Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma. Oncotarget 2017;8:59476-91. [PMID: 28938651 DOI: 10.18632/oncotarget.19761] [Cited by in Crossref: 19] [Cited by in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
24 Wang X, Wang S, Yao G, Yu D, Chen K, Tong Q, Ye L, Wu C, Sun Y, Li H, Hermann DM, Doeppner TR, Jin F, Dai Y, Wu J. Identification of the histone lysine demethylase KDM4A/JMJD2A as a novel epigenetic target in M1 macrophage polarization induced by oxidized LDL. Oncotarget. 2017;8:114442-114456. [PMID: 29383092 DOI: 10.18632/oncotarget.17748] [Cited by in Crossref: 14] [Cited by in RCA: 13] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
25 Turner JG, Dawson JL, Grant S, Shain KH, Dalton WS, Dai Y, Meads M, Baz R, Kauffman M, Shacham S, Sullivan DM. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors. J Hematol Oncol 2016;9:73. [PMID: 27557643 DOI: 10.1186/s13045-016-0304-z] [Cited by in Crossref: 48] [Cited by in RCA: 42] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)]  Open
26 Yao G, Zhang Q, Doeppner TR, Niu F, Li Q, Yang Y, Kuckelkorn U, Hagemann N, Li W, Hermann DM, Dai Y, Zhou W, Jin F. LDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118. Oncotarget 2015;6:30251-62. [PMID: 26388611 DOI: 10.18632/oncotarget.4943] [Cited by in Crossref: 13] [Cited by in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
27 . Erratum. Autophagy 2016;12:443. [PMID: 26902590 DOI: 10.1080/15548627.2016.1147886] [Cited by in Crossref: 31] [Cited by in RCA: 12] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
28 Wan W, Pei XY, Grant S, Birch JB, Felthousen J, Dai Y, Fang HB, Tan M, Sun S. Nonlinear response surface in the study of interaction analysis of three combination drugs. Biom J 2017;59:9-24. [PMID: 27185067 DOI: 10.1002/bimj.201500021] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
29 Zhou L, Chen S, Zhang Y, Kmieciak M, Leng Y, Li L, Lin H, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Rahmani M, Povirk L, Chalasani S, Berger AJ, Dai Y, Grant S. The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR. Blood 2016;127:2219-30. [PMID: 26851293 DOI: 10.1182/blood-2015-06-653717] [Cited by in Crossref: 33] [Cited by in RCA: 30] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
30 Dai Y, Grant S. BCL2L11/Bim as a dual-agent regulating autophagy and apoptosis in drug resistance. Autophagy 2015;11:416-8. [PMID: 25700997 DOI: 10.1080/15548627.2014.998892] [Cited by in Crossref: 31] [Cited by in RCA: 30] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
31 Sullivan DM, Kashyap T, Dawson JL, Landesman Y, Grant S, Shain KH, Dai Y, Kauffman M, Shacham S, Turner JG. Combination Therapy of Selinexor with Bortezomib or Carfilzomib Overcomes Drug Resistance to Proteasome Inhibitors (PI) in Human Multiple Myeloma. Blood 2015;126:3048-3048. [DOI: 10.1182/blood.v126.23.3048.3048] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
32 Turner JG, Dawson JL, Cubitt CL, Baluglo E, Grant S, Dai Y, Shain KH, Dalton WS, Shacham S, Senapedis W, Sullivan DM. Next Generation XPO1 Inhibitor KPT-8602 for the Treatment of Drug-Resistant Multiple Myeloma. Blood 2015;126:1818-1818. [DOI: 10.1182/blood.v126.23.1818.1818] [Cited by in Crossref: 3] [Cited by in RCA: 1] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
33 Lin C, Chen X, Li M, Liu J, Qi X, Yang W, Zhang H, Cai Z, Dai Y, Ouyang X. Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma. Clin Lung Cancer 2015;16:e25-35. [PMID: 25801750 DOI: 10.1016/j.cllc.2015.02.002] [Cited by in Crossref: 68] [Cited by in RCA: 77] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
34 Zang M, Li Z, Liu L, Li F, Li X, Dai Y, Li W, Kuckelkorn U, Doeppner TR, Hermann DM, Zhou W, Qiu L, Jin F. Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma. Cancer Lett 2015;366:173-81. [PMID: 26116344 DOI: 10.1016/j.canlet.2015.06.011] [Cited by in Crossref: 2] [Cited by in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
35 Ouyang Q, Gong X, Xiao H, Zhou J, Xu M, Dai Y, Xu L, Feng H, Cui H, Yi L. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients. Mol Cancer 2015;14:21. [PMID: 25644759 DOI: 10.1186/s12943-015-0290-8] [Cited by in Crossref: 25] [Cited by in RCA: 23] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
36 Turner JG, Dawson JL, Grant S, Shain KH, Dai Y, Cubitt C, Baz R, Nishihori T, Kauffman M, Shacham S, Sullivan DM. Melphalan and XPO1 Inhibitor Combination Therapy for the Treatment of Multiple Myeloma. Blood 2014;124:2084-2084. [DOI: 10.1182/blood.v124.21.2084.2084] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
37 Dai Y, Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, Hui L, Grant S. HDAC Inhibitors Reciprocally Interacts the Wee1 Inhibitor AZD1775 to Abrogate Both the G1/S and G2/M Checkpoints Via Chk1-Related cdc2/Cdk1 Threonine 14 Dephosphorylation in AML Cells. Blood 2014;124:997-997. [DOI: 10.1182/blood.v124.21.997.997] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
38 Dai Y, Rahmani M, Grant S. An Intact NF-kappaB Pathway is Required for Histone Deacetylase Inhibitor Induced G1 Arrest and Maturation in U937 Human Myeloid Leukemia Cells. Cell Cycle 2014;2:465-70. [PMID: 12963846 DOI: 10.4161/cc.2.5.465] [Cited by in Crossref: 25] [Cited by in RCA: 10] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
39 Yu C, Dai Y, Dent P, Grant S. Coadministration of UCN-01 with MEK1/2 Inhibitors Potently Induces Apoptosis in. Cancer Biol Ther 2014;1:674-82. [PMID: 12642693 DOI: 10.4161/cbt.319] [Cited by in Crossref: 19] [Cited by in RCA: 14] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
40 Hawkins W, Mitchell C, Mckinstry R, Gilfor D, Starkey J, Dai Y, Dawson K, Ramakrishnan V, Roberts JD, Yacoub A, Grant S, Dent P. Transient exposure of mammary tumors to PD184352 and UCN-01 causes tumor cell death in vivo and prolonged suppression of tumor re-growth. Cancer Biol Ther 2014;4:1275-84. [PMID: 16319524 DOI: 10.4161/cbt.4.11.2286] [Cited by in Crossref: 14] [Cited by in RCA: 13] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
41 Mckinstry R, Qiao L, Yacoub A, Dai Y, Decker R, Holt S, Grant S, Dent P. Inhibitors of MEK1/2 Interact with UCN-01 to Induce Apoptosis and Reduce Colony Formation in Mammary and Prostate Carcinoma Cells. Cancer Biol Ther 2014;1:243-53. [PMID: 12432271 DOI: 10.4161/cbt.75] [Cited by in Crossref: 34] [Cited by in RCA: 23] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
42 Kiebala M, Skalska J, Casulo C, Brookes PS, Peterson DR, Hilchey SP, Dai Y, Grant S, Maggirwar SB, Bernstein SH. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach. Exp Hematol 2015;43:89-99. [PMID: 25448488 DOI: 10.1016/j.exphem.2014.10.004] [Cited by in Crossref: 30] [Cited by in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
43 Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, Lin H, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Dai Y. A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations. Leukemia. 2015;29:807-818. [PMID: 25283841 DOI: 10.1038/leu.2014.296] [Cited by in Crossref: 48] [Cited by in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)]
44 Chen S, Zhang Y, Zhou L, Leng Y, Lin H, Kmieciak M, Pei XY, Jones R, Orlowski RZ, Dai Y, Grant S. A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. Blood 2014;124:2687-97. [PMID: 25208888 DOI: 10.1182/blood-2014-03-564534] [Cited by in Crossref: 66] [Cited by in RCA: 60] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
45 Gu D, Wang S, Kuiatse I, Wang H, He J, Dai Y, Jones RJ, Bjorklund CC, Yang J, Grant S, Orlowski RZ. Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737. PLoS One 2014;9:e103015. [PMID: 25181509 DOI: 10.1371/journal.pone.0103015] [Cited by in Crossref: 21] [Cited by in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
46 Chen S, Zhou L, Zhang Y, Leng Y, Pei XY, Lin H, Jones R, Orlowski RZ, Dai Y, Grant S. Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik. Mol Cell Biol 2014;34:3435-49. [PMID: 25002530 DOI: 10.1128/MCB.01383-13] [Cited by in Crossref: 51] [Cited by in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
47 Wang J, Jiang Z, Xiang L, Li Y, Ou M, Yang X, Shao J, Lu Y, Lin L, Chen J, Dai Y, Jia L. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis. Sci Rep 2014;4:5006. [PMID: 25833312 DOI: 10.1038/srep05006] [Cited by in Crossref: 51] [Cited by in RCA: 53] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)]  Open
48 Bose P, Dai Y, Grant S. Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. Pharmacol Ther. 2014;143:323-336. [PMID: 24769080 DOI: 10.1016/j.pharmthera.2014.04.004] [Cited by in Crossref: 172] [Cited by in RCA: 154] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [What about the content of this article? (0)]
49 Booth L, Cruickshanks N, Ridder T, Dai Y, Grant S, Dent P. PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells. Cancer Biol Ther 2013;14:458-65. [PMID: 23917378 DOI: 10.4161/cbt.24424] [Cited by in Crossref: 48] [Cited by in RCA: 40] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
50 Pei XY, Dai Y, Felthousen J, Chen S, Takabatake Y, Zhou L, Youssefian LE, Sanderson MW, Bodie WW, Kramer LB, Orlowski RZ, Grant S. Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells. PLoS One 2014;9:e89064. [PMID: 24594907 DOI: 10.1371/journal.pone.0089064] [Cited by in Crossref: 23] [Cited by in RCA: 18] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
PrevPage 1 of 3 123Next
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA